Lou Gehrig: The Human Face of ALS

June 2 is Lou Gehrig Day, dedicated to promoting awareness about amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. At Worldwide Clinical Trials, our CNS experts are sharing their reflections on the importance of ALS research and what gives them hope for the future. In this piece, Richard Koenig, Executive Director of Project Management for Psychiatry and Neuroscience Rare Diseases, discusses the role of public awareness initiatives in changing the future for ALS patients.
Read More